Volume 14, Number 7—July 2008
CME ACTIVITY - Research
Alcaligenes xylosoxidans Bloodstream Infections in Outpatient Oncology Office
|Case-patient no.||Age, y||Sex||Underlying disease||Date of CVC flush||Date of onset, symptoms†||Date of blood collection‡|
|1||70||F||Acute myelogenous leukemia||2001 Nov 19||2001 Nov 19, rigors after flush||2001 Nov 19|
|2||65||F||Breast cancer||2001 Dec 5||2001 Dec 5, no chart record of symptoms after flush, blood culture obtained next day||2001 Dec 6|
|3||73||F||Colon cancer||2001 Dec 7||2001 Dec 7, fever after flush||2001 Dec 7|
|4||41||F||Sickle cell disease||2001 Dec 4||2001 Dec 11, myalgias, emesis||2001 Dec 11|
|5||73||F||Gastric cancer||Unknown||Unknown||2001 Dec 13|
|6||71||M||Colon cancer||2001 Dec18||2001 Dec 19, fever, chills||2001 Dec 20|
|7||79||F||Pancreatic cancer||Unknown||Unknown||2001 Dec 30|
|8||45||F||Breast cancer||2002 Jan 10||2002 Jan 10, no chart record of symptoms after flush, blood culture obtained next day||2001 Jan 10|
||2002 Jan 10
||2002 Jan 10, hypotension after infusion
||2002 Jan 11
|10||77||F||Squamous cell cancer of palate||NA||2001 Nov/Dec, intermittent nausea and weakness||2002 Jan 29|
|11||77||M||Gastric cancer||NA||2001 Nov/Dec, intermittent fever, chills after flushes, not reported to Office B staff||2002 Feb 7|
|12||49||F||Non-Hodgkin lymphoma||NA||Asymptomatic||2002 Feb 5|
*CVC, central venous catheter; NA, not applicable.
†Signs and symptoms of bloodstream infection.
‡Collection of blood that had subsequent positive culture result for A. xylosoxidans.
Page created: July 12, 2010
Page updated: July 12, 2010
Page reviewed: July 12, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.